-
Tesla shares fall as Musk touts ambitious -- and costly -- plans
-
June heatwave cost UK economy more than £1bn: study
-
Houthis claim Red Sea tanker strikes as US hits Iran again
-
Google-parent Alphabet beats expectations, cloud revenue nearly doubles
-
Wildfires ravage parts of southern France, Italy and Spain
-
US announces civilian nuclear deal with Saudi Arabia
-
Alphabet beats expectations in second quarter, cloud revenue nearly doubles
-
Tesla shares dip after profit misses expectations
-
Trump threatens Iran infrastructure, Tehran vows 'eye for eye'
-
Red Sox tie club record with 15th straight MLB win
-
US teen withdraws lawsuit against Meta over social media addiction
-
US eyes offshore nuclear reactors
-
Lebanon PM says Beirut working for 'complete Israeli withdrawal'
-
The Sterling Announces Luxury Cocktail Lounge Concept and Investor Showcase in Orlando
-
EU conditionally clears Paramount bid for Warner Bros.
-
Inter Miami signs Brazil veteran Casemiro but MLS probes deal
-
Philipsen snaps 'horrible' drought with Tour de France stage 17 victory
-
White House accuses China's Moonshot of stealing Anthropic AI
-
US trial of Venezuela's Maduro set for June 2027
-
Pogacar sweating on Yates's fitness ahead of Tour Queen stage
-
New UK PM Burnham gets early boost as inflation dips
-
Ukrainian soldiers and civilians welcome new army commander
-
Samsung launches new, more expensive foldable smartphones
-
UK fintech Revolut valuation soars to $115 bn: source
-
Philipsen ends 'horrible' drought with Tour de France 17th stage victory
-
German FM, on Africa tour, eyes business ties amid US, China pressure
-
Hungary's Orban says graft case is 'pretext' to target his party
-
Rubio says at ASEAN meeting he expects 'positive' US visit by China's Xi
-
South African tycoon Motsepe rules out presidential bid
-
Philipsen wins Tour de France 17th stage
-
Trump threatens Iran bridges, power as payback for Hormuz attacks
-
DonnaPro Introduces AI-Trained Executive Assistants for European CEOs
-
Germany's Merz replaces leader ousted over surrogacy row
-
Happy birthday, George! UK prince becomes a teenager
-
CAF chief Motsepe backs Infantino despite criticism
-
Oil prices jump on Mideast war, stock markets diverge
-
Evacuees from Spain's wildfire struggle with scale of devastation
-
US hits Iranian island, says war cost at $37.5 bn
-
Ancient Lebanese city of Tyre added to heritage danger list
-
Metal mining's carbon footprint far larger than thought: study
-
Extreme heatwave grips Tunisia as wide power cuts fuel frustration
-
TokenInsight Q2 2026 Report: TradFi Momentum Lifts MEXC to No. 2 in Commodity Perpetuals
-
'Beautiful game' provides Venezuelans with welcome distraction in wake of tragedy
-
Leonardo chief sees potential for Germany to join GCAP fighter jet project
-
Oil prices surge on Mideast war, stock markets diverge
-
Louvre heist gallery reopens to public, but with nothing to steal
-
Fury says 'best yet to come' ahead of Thailand fight
-
Ukraine's new army chief: who is Mykhailo Drapaty?
-
Japan suffers heat 'disaster as cities hit by 'cruelly hot' days
-
India student protests keep up pressure on Modi government
'Ketamine Queen' to plead guilty over drugs that killed Matthew Perry
A dealer dubbed the "Ketamine Queen" has agreed to plead guilty to supplying the drugs that killed "Friends" actor Matthew Perry, the US Department of Justice said Monday.
Jasveen Sangha, 42, will admit several charges, including one of distribution of ketamine resulting in death or serious bodily injury in relation to the late star.
Sangha, who is expected to formally enter her pleas in the coming weeks, is a dual citizen of the United States and the United Kingdom. She has been in federal custody since August 2024.
She will become the fifth person to admit playing a part in the death of the beloved actor, who had openly struggled for decades with substance addiction.
Perry was found dead in the hot tub of his Los Angeles home in 2023 at the age of 54.
A criminal investigation was launched soon after an autopsy discovered he had high levels of ketamine -- an anesthetic -- in his system.
Last month Dr Salvador Plasencia pleaded guilty to four counts of distribution of ketamine in the weeks before Perry's death.
Another doctor, Mark Chavez, admitted last year to conspiring to distribute ketamine to Perry.
Plasencia allegedly bought ketamine off Chavez and sold it to the American-Canadian actor at hugely inflated prices.
"I wonder how much this moron will pay," Plasencia wrote in one text message.
According to her plea agreement, Sangha worked with a middleman, Erik Fleming, to sell 51 vials of ketamine to Perry's live-in personal assistant, Kenneth Iwamasa.
Iwamasa repeatedly injected Perry with the ketamine that Sangha supplied, including on October 28, 2023, when he administered at least three shots of Sangha's ketamine, which killed the actor.
The Department of Justice said when she heard news reports about Perry's sudden death, Sangha tried to cover her tracks.
"Delete all our messages," she instructed Fleming.
Perry had been taking ketamine as part of supervised therapy for depression.
But prosecutors say that before his death he became addicted to the substance, which also has psychedelic properties and is a popular party drug.
"Friends," which followed the lives of six New Yorkers navigating adulthood, dating and careers, drew a massive following and made megastars of previously unknown actors.
Perry's role as the sarcastic man-child Chandler brought him fabulous wealth, but hid a dark struggle with addiction to painkillers and alcohol.
In 2018, he suffered a drug-related burst colon and underwent multiple surgeries.
In his 2022 memoir "Friends, Lovers and the Big Terrible Thing," Perry described going through detox dozens of times.
"I have mostly been sober since 2001," he wrote, "save for about sixty or seventy little mishaps."
S.Spengler--VB